RecruitingNot ApplicableNCT06262893

Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy


Sponsor

Assiut University

Enrollment

60 participants

Start Date

Feb 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In this study the investigators aim to compare the effect of the suprascapular- supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on analgesic effect during arthroscopic shoulder surgery, as postoperative pain scores ,postoperative consumption of analgesic rescue medications and diaphragmatic excursion assessment.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • ASA status 1,2.
  • Age 18 years or older
  • Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively.

Exclusion Criteria11

  • • Patient refusal
  • Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease.
  • Use of drugs that act on the autonomic nervous system (including β- blockers).
  • Coagulation disorders..
  • Anatomical disorders and/or neuropathic disease.
  • BMI above 40.
  • History of substance abuse.
  • Chronic use of psychotropic and/or opioid.
  • History of psychiatric diseases needing treatment.
  • Allergy to any drug in the study protocol.
  • Failure of nerve block performed in the preoperative block room when tested prior to entering the operating room (i.e. lack of loss of sensation to ice at the shoulder incision level).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREShoulder arthroscopy blocks

Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.


Locations(1)

Assiut University

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06262893


Related Trials